Nov 29 2024
According to the results of a newly published study conducted in Utah, cannabis has the potential to to serve as an alternative to opioids for chronic pain management. For the study, published on Utah.gov, researchers analyzed the impact of medical cannabis on opioid prescription rates, focusing on 186 patients with chronic pain diagnoses. The study …
Nov 29 2024
A new study published in the journal Pharmacological Reports highlights the therapeutic potential of four newly developed fluorinated cannabinoids. Conducted by researchers from Oklahoma State University Center for Health Sciences and Universität Regensburg in Germany, the study explores the biological activity of these compounds, particularly their anti-inflammatory properties. “Phytochemicals derived from the plant Cannabis sativa …
Nov 29 2024
Researchers from Suleyman Demirel University and Alanya Alaaddin Keykubat University in Turkey have found that cannabidiol (CBD) may alleviate liver damage caused by methotrexate (MTX), a commonly used chemotherapy drug. The study, published in Drug and Chemical Toxicology, highlights CBD’s potential as a protective agent against MTX-induced hepatotoxicity by targeting oxidative stress and inflammation. The research …
Nov 29 2024
Researchers from Nationwide Children’s Hospital and The Ohio State University have published a new study examining the effects of medical marijuana legalization on attitudes and behaviors toward driving after marijuana use (DAMU) in Kentucky and Tennessee. Using survey data, researchers applied a novel matched design to infer causal relationships while accounting for observational data challenges …
Nov 27 2024
A new systematic review published in the International Journal of Molecular Sciences explores the potential role of cannabidiol (CBD)-rich cannabis in managing symptoms of autism spectrum disorder (ASD). The study, conducted by researchers from LUM University, G. d’Annunzio University, and the Università Politecnica delle Marche, highlights both the promise and the limitations of this emerging treatment. ASD …
Nov 26 2024
A study published in the journal Phytomedicine, conducted by researchers from the China-Japan Friendship Hospital, investigates how cannabidiol (CBD) influences gut microbiota and metabolic pathways to alleviate symptoms of rheumatoid arthritis (RA). “Rheumatoid arthritis (RA) is one of the most common autoimmune diseases, affecting multiple systems in the body”, states the study’s abstract. “Cannabidiol (CBD) …
Nov 26 2024
A randomized, double-blind, placebo-controlled study published in SLEEP by Oxford Academic found that a combination treatment of dronabinol (IHL-42X), a synthetic form of THC, and acetazolamide, significantly reduced the severity of obstructive sleep apnea (OSA). Conducted by researchers from The University of Western Australia, Monash University, and several Australian hospitals, the study explored the safety …
Nov 25 2024
A study published in The Cureus Journal of Medical Science highlights the potential benefits of cannabinoid use for patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Conducted by researchers from Concentra Urgent Care (Orlando), the University of Central Florida College of Medicine, the University of Alabama at Birmingham School of Medicine, and the University …
Nov 22 2024
With marijuana use surging among older adults, researchers are uncovering how it may influence age-related cognitive decline. A new study, published by the National Library of Medicine and as a preprint in bioRxiv, reveals that cannabis and Δ9-tetrahydrocannabinol (Δ9THC) may enhance working memory in aged individuals without worsening other cognitive impairments. The study concluded that …
Nov 21 2024
A recent study featured in the journal Pain Practice reveals that individuals living with chronic pain experience significant and sustained relief in pain severity and related symptoms through the use of medical marijuana. Drawing on data from the UK Medical Cannabis Registry, the research tracked patient-reported outcomes over a 12-month period, shedding light on the …
